Predictors of response after intravitreal bevacizumab injection for neovascular age-related macular degeneration

被引：0
|
作者：
Yeo Jue Byun
Sung Jun Lee
Hyoung Jun Koh
机构：
[1] Yonsei University College of Medicine,Institute of Vision Research, Department of Ophthalmology
[2] Dongguk University School of Medicine,Department of Ophthalmology, Dongguk University Ilsan Hospital
[3] Yonsei University College of Medicine,Department of Ophthalmology
来源：
Japanese Journal of Ophthalmology | 2010年 / 54卷
关键词：
AMD; bevacizumab; nonresponders; OCT; responders;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：571 / 577
页数：6
相关论文
共 50 条
  • [11] Systemic and intravitreal Bevacizumab (Avastin®) in neovascular age-related macular degeneration
    Michels, S.
    Prager, F.
    Geitzenauer, W.
    Lackner, B.
    Sacu, S.
    Weigert, G.
    Kriechbaum, K.
    Polak, K.
    Georgopoulos, M.
    Schmidt-Erfurth, U.
    SPEKTRUM DER AUGENHEILKUNDE, 2007, 21 (03) : 154 - 159
  • [12] Intravitreal bevacizumab (avastin) in treatment of neovascular age-related macular degeneration
    Lazic, Ratimir
    Gabric, Nikica
    Dekaris, Iva
    Saric, Borna
    Gavric, Morena
    COLLEGIUM ANTROPOLOGICUM, 2007, 31 : 77 - 81
  • [13] Intravitreal Bevacizumab Injection in Patients With Neovascular Age-Related Macular Degeneration and Low Visual Acuity
    El Matri, L.
    Bouraoui, R.
    Landolsi, H.
    Kort, F.
    Chebil, A.
    Limaiem, R.
    Mghaieth, F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [14] Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for neovascular age-related macular degeneration
    Rosenfeld, PJ
    Moshfeghi, AA
    Puliafito, CA
    OPHTHALMIC SURGERY LASERS & IMAGING, 2005, 36 (04): : 331 - 335
  • [15] Retinal pigment epithelium tears after intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration
    Ronan, Shawn M.
    Yoganathan, Pradeepa
    Chien, Fred Y.
    Corcostegui, Inigo A.
    Blumenkranz, Mark S.
    Deramo, Vincent A.
    Elner, Susan G.
    Fastenberg, David A.
    Johnson, Mark W.
    Lopez, Mauricio
    Mateo, Carlos
    Moshfeghi, Darius M.
    Navarro, Rafael
    Rosenblatt, Brett J.
    Sanislo, Steven R.
    Saxe, Stephen J.
    Zacks, David N.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (05): : 535 - 540
  • [16] Increased electroretinogram a-wave amplitude after intravitreal bevacizumab injection for neovascular age-related macular degeneration
    Skaat, Alon
    Solomon, Arie
    Moroz, Iris
    Hai, Orit Vidne
    Rechtman, Ehud
    Dai, Vicktoria Vishnevskia
    Rotenstreich, Ygal
    ACTA OPHTHALMOLOGICA, 2011, 89 (03) : e269 - e273
  • [17] Subfoveal choroidal thickness changes after intravitreal bevacizumab injection for neovascular age-related macular degeneration and diabetic macular edema
    Unlu, Cihan
    Erdogan, Gurkan
    Gunay, Betul Onal
    Kardes, Esra
    Akcay, Betul Ilkay Sezgin
    Ergin, Ahmet
    INTERNATIONAL OPHTHALMOLOGY, 2017, 37 (01) : 147 - 158
  • [18] Subfoveal choroidal thickness changes after intravitreal bevacizumab injection for neovascular age-related macular degeneration and diabetic macular edema
    Cihan Ünlü
    Gurkan Erdogan
    Betul Onal Gunay
    Esra Kardes
    Betul Ilkay Sezgin Akcay
    Ahmet Ergin
    International Ophthalmology, 2017, 37 : 147 - 158
  • [19] Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration
    Ohr, Matthew
    Kaiser, Peter K.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (04) : 585 - 591
  • [20] Visual hallucinations after intravitreal injection of ranibizumab in neovascular age-related macular degeneration
    Tan, C. S. H.
    EYE, 2011, 25 (10) : 1374 - 1374
12345